Health news
Dietary intake may precipitate migraine attacks, with up to 60% of patients reporting exacerbations following consumption of specific foods and beverages. Chocolate, coffee, cheese, and alcohol are among the most commonly identified migraine triggers across…
Treatment with erenumab-aooe, a calcitonin gene-related peptide (CGRP) receptor antagonist, was associated with superior efficacy and a lower discontinuation rate vs topiramate in adults with episodic or chronic migraine, according to findings from a phase…
Chronic migraine affects an estimated 1.4%-2.2% of people worldwide, with a preponderance of cases in women (1.7%-4.0%) compared to men (0.6%-0.7%). Each year, approximately 3% of individuals with episodic migraine progress to chronic migraine.1 In…
Newer migraine pharmacotherapies appear to be less effective than triptans, according to findings from a systematic review and meta-analysis published in JAMA Network Open. Newer medication classes include the 5-hydroxytryptamine1F receptor agonists (lasmiditan) and the…
Trudhesa (dihydroergotamine mesylate) nasal spray is now available for the acute treatment of migraine with or without aura in adults. Trudhesa uses proprietary technology to deliver a lower dose (0.725mg per spray) of dihydroergotamine mesylate…
The Food and Drug Administration has accepted the New Drug Application for AXS-07 for the acute treatment of migraine. AXS-07 is an oral agent that consists of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug, and…
The Food and Drug Administration has approved Trudhesa (dihydroergotamine mesylate) nasal spray for the acute treatment of migraine with or without aura in adults. Trudhesa uses proprietary technology to deliver a lower dose (0.725mg per…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021